COVID-19 Outbreak-Global Anti-malarial Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Publication Month: May 2021 | No. of Pages: 115 Published By: Maia Research
Single User License: US $ 3660
Corporate User License: US $ 7320

Antimalarials drugs are used to prevent or treat malaria. Representative drugs include quinine, chloroquine, artemisinin, etc.
The Anti-malarial Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Anti-malarial Drugs industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Anti-malarial Drugs market can be split based on product types, major applications, and important countries as follows:

Key players in the global Anti-malarial Drugs market covered in Chapter 12:
Mylan Labs
Novartis AG
Cipla
Merck KGaA
Alvizia Health Care
Bayer AG
Ranbaxy Laboratories
F. Hoffmann-La Roche AG
Strides Pharma Science
Pfizer, Inc.
Ipca Laboratories Ltd
GlaxoSmithKline Plc

In Chapter 4 and 14.1, on the basis of types, the Anti-malarial Drugs market from 2015 to 2025 is primarily split into:
Blood Schizonticides
Gametocytocides
Sporontocides
Others

In Chapter 5 and 14.2, on the basis of applications, the Anti-malarial Drugs market from 2015 to 2025 covers:
Falciparum Malaria
Vivax Malaria
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Table of Content

1 Anti-malarial Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Anti-malarial Drugs
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Anti-malarial Drugs industry
1.4 Methodology of The Study
1.5 Research Data Source

2 Executive Summary
2.1 Market Overview
2.1.1 Global Anti-malarial Drugs Market Size, 2015 - 2020
2.1.2 Global Anti-malarial Drugs Market Size by Type, 2015 - 2020
2.1.3 Global Anti-malarial Drugs Market Size by Application, 2015 - 2020
2.1.4 Global Anti-malarial Drugs Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Anti-malarial Drugs Industry Development

3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Anti-malarial Drugs Analysis
3.2 Major Players of Anti-malarial Drugs
3.3 Anti-malarial Drugs Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Anti-malarial Drugs
3.3.3 Labor Cost of Anti-malarial Drugs
3.4 Market Distributors of Anti-malarial Drugs
3.5 Major Downstream Buyers of Anti-malarial Drugs Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally

4 Global Anti-malarial Drugs Market, by Type
4.1 Global Anti-malarial Drugs Value and Market Share by Type (2015-2020)
4.2 Global Anti-malarial Drugs Production and Market Share by Type (2015-2020)
4.3 Global Anti-malarial Drugs Value and Growth Rate by Type (2015-2020)
4.3.1 Global Anti-malarial Drugs Value and Growth Rate of Blood Schizonticides
4.3.2 Global Anti-malarial Drugs Value and Growth Rate of Gametocytocides
4.3.3 Global Anti-malarial Drugs Value and Growth Rate of Sporontocides
4.3.4 Global Anti-malarial Drugs Value and Growth Rate of Others
4.4 Global Anti-malarial Drugs Price Analysis by Type (2015-2020)

5 Anti-malarial Drugs Market, by Application
5.1 Downstream Market Overview
5.2 Global Anti-malarial Drugs Consumption and Market Share by Application (2015-2020)
5.3 Global Anti-malarial Drugs Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Anti-malarial Drugs Consumption and Growth Rate of Falciparum Malaria (2015-2020)
5.3.2 Global Anti-malarial Drugs Consumption and Growth Rate of Vivax Malaria (2015-2020)
5.3.3 Global Anti-malarial Drugs Consumption and Growth Rate of Others (2015-2020)

6 Global Anti-malarial Drugs Market Analysis by Regions
6.1 Global Anti-malarial Drugs Sales, Revenue and Market Share by Regions
6.1.1 Global Anti-malarial Drugs Sales by Regions (2015-2020)
6.1.2 Global Anti-malarial Drugs Revenue by Regions (2015-2020)
6.2 North America Anti-malarial Drugs Sales and Growth Rate (2015-2020)
6.3 Europe Anti-malarial Drugs Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Anti-malarial Drugs Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Anti-malarial Drugs Sales and Growth Rate (2015-2020)
6.6 South America Anti-malarial Drugs Sales and Growth Rate (2015-2020)

7 North America Anti-malarial Drugs Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Anti-malarial Drugs Sales, Revenue and Market Share by Countries
7.2.1 North America Anti-malarial Drugs Sales by Countries (2015-2020)
7.2.2 North America Anti-malarial Drugs Revenue by Countries (2015-2020)
7.3 United States Anti-malarial Drugs Sales and Growth Rate (2015-2020)
7.4 Canada Anti-malarial Drugs Sales and Growth Rate (2015-2020)
7.5 Mexico Anti-malarial Drugs Sales and Growth Rate (2015-2020)

8 Europe Anti-malarial Drugs Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Anti-malarial Drugs Sales, Revenue and Market Share by Countries
8.2.1 Europe Anti-malarial Drugs Sales by Countries (2015-2020)
8.2.2 Europe Anti-malarial Drugs Revenue by Countries (2015-2020)
8.3 Germany Anti-malarial Drugs Sales and Growth Rate (2015-2020)
8.4 UK Anti-malarial Drugs Sales and Growth Rate (2015-2020)
8.5 France Anti-malarial Drugs Sales and Growth Rate (2015-2020)
8.6 Italy Anti-malarial Drugs Sales and Growth Rate (2015-2020)
8.7 Spain Anti-malarial Drugs Sales and Growth Rate (2015-2020)
8.8 Russia Anti-malarial Drugs Sales and Growth Rate (2015-2020)

9 Asia Pacific Anti-malarial Drugs Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Anti-malarial Drugs Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Anti-malarial Drugs Sales by Countries (2015-2020)
9.2.2 Asia Pacific Anti-malarial Drugs Revenue by Countries (2015-2020)
9.3 China Anti-malarial Drugs Sales and Growth Rate (2015-2020)
9.4 Japan Anti-malarial Drugs Sales and Growth Rate (2015-2020)
9.5 South Korea Anti-malarial Drugs Sales and Growth Rate (2015-2020)
9.6 India Anti-malarial Drugs Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Anti-malarial Drugs Sales and Growth Rate (2015-2020)
9.8 Australia Anti-malarial Drugs Sales and Growth Rate (2015-2020)

10 Middle East and Africa Anti-malarial Drugs Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Anti-malarial Drugs Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Anti-malarial Drugs Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Anti-malarial Drugs Revenue by Countries (2015-2020)
10.3 Saudi Arabia Anti-malarial Drugs Sales and Growth Rate (2015-2020)
10.4 UAE Anti-malarial Drugs Sales and Growth Rate (2015-2020)
10.5 Egypt Anti-malarial Drugs Sales and Growth Rate (2015-2020)
10.6 Nigeria Anti-malarial Drugs Sales and Growth Rate (2015-2020)
10.7 South Africa Anti-malarial Drugs Sales and Growth Rate (2015-2020)

11 South America Anti-malarial Drugs Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Anti-malarial Drugs Sales, Revenue and Market Share by Countries
11.2.1 South America Anti-malarial Drugs Sales by Countries (2015-2020)
11.2.2 South America Anti-malarial Drugs Revenue by Countries (2015-2020)
11.3 Brazil Anti-malarial Drugs Sales and Growth Rate (2015-2020)
11.4 Argentina Anti-malarial Drugs Sales and Growth Rate (2015-2020)
11.5 Columbia Anti-malarial Drugs Sales and Growth Rate (2015-2020)
11.6 Chile Anti-malarial Drugs Sales and Growth Rate (2015-2020)

12 Competitive Landscape
12.1 Mylan Labs
12.1.1 Mylan Labs Basic Information
12.1.2 Anti-malarial Drugs Product Introduction
12.1.3 Mylan Labs Production, Value, Price, Gross Margin 2015-2020
12.2 Novartis AG
12.2.1 Novartis AG Basic Information
12.2.2 Anti-malarial Drugs Product Introduction
12.2.3 Novartis AG Production, Value, Price, Gross Margin 2015-2020
12.3 Cipla
12.3.1 Cipla Basic Information
12.3.2 Anti-malarial Drugs Product Introduction
12.3.3 Cipla Production, Value, Price, Gross Margin 2015-2020
12.4 Merck KGaA
12.4.1 Merck KGaA Basic Information
12.4.2 Anti-malarial Drugs Product Introduction
12.4.3 Merck KGaA Production, Value, Price, Gross Margin 2015-2020
12.5 Alvizia Health Care
12.5.1 Alvizia Health Care Basic Information
12.5.2 Anti-malarial Drugs Product Introduction
12.5.3 Alvizia Health Care Production, Value, Price, Gross Margin 2015-2020
12.6 Bayer AG
12.6.1 Bayer AG Basic Information
12.6.2 Anti-malarial Drugs Product Introduction
12.6.3 Bayer AG Production, Value, Price, Gross Margin 2015-2020
12.7 Ranbaxy Laboratories
12.7.1 Ranbaxy Laboratories Basic Information
12.7.2 Anti-malarial Drugs Product Introduction
12.7.3 Ranbaxy Laboratories Production, Value, Price, Gross Margin 2015-2020
12.8 F. Hoffmann-La Roche AG
12.8.1 F. Hoffmann-La Roche AG Basic Information
12.8.2 Anti-malarial Drugs Product Introduction
12.8.3 F. Hoffmann-La Roche AG Production, Value, Price, Gross Margin 2015-2020
12.9 Strides Pharma Science
12.9.1 Strides Pharma Science Basic Information
12.9.2 Anti-malarial Drugs Product Introduction
12.9.3 Strides Pharma Science Production, Value, Price, Gross Margin 2015-2020
12.10 Pfizer, Inc.
12.10.1 Pfizer, Inc. Basic Information
12.10.2 Anti-malarial Drugs Product Introduction
12.10.3 Pfizer, Inc. Production, Value, Price, Gross Margin 2015-2020
12.11 Ipca Laboratories Ltd
12.11.1 Ipca Laboratories Ltd Basic Information
12.11.2 Anti-malarial Drugs Product Introduction
12.11.3 Ipca Laboratories Ltd Production, Value, Price, Gross Margin 2015-2020
12.12 GlaxoSmithKline Plc
12.12.1 GlaxoSmithKline Plc Basic Information
12.12.2 Anti-malarial Drugs Product Introduction
12.12.3 GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release

14 Global Anti-malarial Drugs Market Forecast
14.1 Global Anti-malarial Drugs Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Blood Schizonticides Market Value and Volume Forecast (2020-2025)
14.1.2 Gametocytocides Market Value and Volume Forecast (2020-2025)
14.1.3 Sporontocides Market Value and Volume Forecast (2020-2025)
14.1.4 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Anti-malarial Drugs Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Falciparum Malaria Market Value and Volume Forecast (2020-2025)
14.2.2 Vivax Malaria Market Value and Volume Forecast (2020-2025)
14.2.3 Others Market Value and Volume Forecast (2020-2025)
14.3 Anti-malarial Drugs Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment

Tables and Figures

List of Tables and Figures

Figure Product Picture of Anti-malarial Drugs
Table Product Specification of Anti-malarial Drugs
Table Anti-malarial Drugs Key Market Segments
Table Key Players Anti-malarial Drugs Covered
Figure Global Anti-malarial Drugs Market Size, 2015 - 2025
Table Different Types of Anti-malarial Drugs
Figure Global Anti-malarial Drugs Value ($) Segment by Type from 2015-2020
Figure Global Anti-malarial Drugs Market Share by Types in 2019
Table Different Applications of Anti-malarial Drugs
Figure Global Anti-malarial Drugs Value ($) Segment by Applications from 2015-2020
Figure Global Anti-malarial Drugs Market Share by Applications in 2019
Figure Global Anti-malarial Drugs Market Share by Regions in 2019
Figure North America Anti-malarial Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Europe Anti-malarial Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Anti-malarial Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-malarial Drugs Production Value ($) and Growth Rate (2015-2020)
Figure South America Anti-malarial Drugs Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Anti-malarial Drugs
Table Upstream Raw Material Suppliers of Anti-malarial Drugs with Contact Information
Table Major Players Headquarters, and Service Area of Anti-malarial Drugs
Figure Major Players Production Value Market Share of Anti-malarial Drugs in 2019
Table Major Players Anti-malarial Drugs Product Types in 2019
Figure Production Process of Anti-malarial Drugs
Figure Manufacturing Cost Structure of Anti-malarial Drugs
Figure Channel Status of Anti-malarial Drugs
Table Major Distributors of Anti-malarial Drugs with Contact Information
Table Major Downstream Buyers of Anti-malarial Drugs with Contact Information
Table Global Anti-malarial Drugs Value ($) by Type (2015-2020)
Table Global Anti-malarial Drugs Value Share by Type (2015-2020)
Figure Global Anti-malarial Drugs Value Share by Type (2015-2020)
Table Global Anti-malarial Drugs Production by Type (2015-2020)
Table Global Anti-malarial Drugs Production Share by Type (2015-2020)
Figure Global Anti-malarial Drugs Production Share by Type (2015-2020)
Figure Global Anti-malarial Drugs Value ($) and Growth Rate of Blood Schizonticides (2015-2020)
Figure Global Anti-malarial Drugs Value ($) and Growth Rate of Gametocytocides (2015-2020)
Figure Global Anti-malarial Drugs Value ($) and Growth Rate of Sporontocides (2015-2020)
Figure Global Anti-malarial Drugs Value ($) and Growth Rate of Others (2015-2020)
Figure Global Anti-malarial Drugs Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Anti-malarial Drugs Consumption by Application (2015-2020)
Table Global Anti-malarial Drugs Consumption Market Share by Application (2015-2020)
Figure Global Anti-malarial Drugs Consumption Market Share by Application (2015-2020)
Figure Global Anti-malarial Drugs Consumption and Growth Rate of Falciparum Malaria (2015-2020)
Figure Global Anti-malarial Drugs Consumption and Growth Rate of Vivax Malaria (2015-2020)
Figure Global Anti-malarial Drugs Consumption and Growth Rate of Others (2015-2020)
Figure Global Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Global Anti-malarial Drugs Revenue (M USD) and Growth (2015-2020)
Table Global Anti-malarial Drugs Sales by Regions (2015-2020)
Table Global Anti-malarial Drugs Sales Market Share by Regions (2015-2020)
Table Global Anti-malarial Drugs Revenue (M USD) by Regions (2015-2020)
Table Global Anti-malarial Drugs Revenue Market Share by Regions (2015-2020)
Table Global Anti-malarial Drugs Revenue Market Share by Regions in 2015
Table Global Anti-malarial Drugs Revenue Market Share by Regions in 2019
Figure North America Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Europe Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure South America Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Anti-malarial Drugs Revenue (M USD) and Growth (2015-2020)
Table North America Anti-malarial Drugs Sales by Countries (2015-2020)
Table North America Anti-malarial Drugs Sales Market Share by Countries (2015-2020)
Table North America Anti-malarial Drugs Revenue (M USD) by Countries (2015-2020)
Table North America Anti-malarial Drugs Revenue Market Share by Countries (2015-2020)
Figure United States Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Canada Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Mexico Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Anti-malarial Drugs Revenue (M USD) and Growth (2015-2020)
Table Europe Anti-malarial Drugs Sales by Countries (2015-2020)
Table Europe Anti-malarial Drugs Sales Market Share by Countries (2015-2020)
Table Europe Anti-malarial Drugs Revenue (M USD) by Countries (2015-2020)
Table Europe Anti-malarial Drugs Revenue Market Share by Countries (2015-2020)
Figure Germany Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure UK Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure France Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Italy Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Spain Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Russia Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Anti-malarial Drugs Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Anti-malarial Drugs Sales by Countries (2015-2020)
Table Asia Pacific Anti-malarial Drugs Sales Market Share by Countries (2015-2020)
Table Asia Pacific Anti-malarial Drugs Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Anti-malarial Drugs Revenue Market Share by Countries (2015-2020)
Figure China Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Japan Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure South Korea Anti-malarial Drugs Sales and Growth (2015-2020)
Figure India Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Southeast Asia Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Australia Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Middle East Anti-malarial Drugs Revenue (M USD) and Growth (2015-2020)
Table Middle East Anti-malarial Drugs Sales by Countries (2015-2020)
Table Middle East and Africa Anti-malarial Drugs Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Anti-malarial Drugs Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Anti-malarial Drugs Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure UAE Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Egypt Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Nigeria Anti-malarial Drugs Sales and Growth (2015-2020)
Figure South Africa Anti-malarial Drugs Sales and Growth (2015-2020)
Figure South America Anti-malarial Drugs Revenue (M USD) and Growth (2015-2020)
Table South America Anti-malarial Drugs Sales by Countries (2015-2020)
Table South America Anti-malarial Drugs Sales Market Share by Countries (2015-2020)
Table South America Anti-malarial Drugs Revenue (M USD) by Countries (2015-2020)
Table South America Anti-malarial Drugs Revenue Market Share by Countries (2015-2020)
Figure Brazil Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Argentina Anti-malarial Drugs Sales and Growth Rate (2015-2020)
Figure Columbia Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Chile Anti-malarial Drugs Sales and Growth (2015-2020)
Figure Top 3 Market Share of Anti-malarial Drugs Companies in 2019
Figure Top 6 Market Share of Anti-malarial Drugs Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Mylan Labs Profile
Table Mylan Labs Product Introduction
Figure Mylan Labs Production and Growth Rate
Figure Mylan Labs Value ($) Market Share 2015-2020
Table Novartis AG Profile
Table Novartis AG Product Introduction
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Cipla Profile
Table Cipla Product Introduction
Figure Cipla Production and Growth Rate
Figure Cipla Value ($) Market Share 2015-2020
Table Merck KGaA Profile
Table Merck KGaA Product Introduction
Figure Merck KGaA Production and Growth Rate
Figure Merck KGaA Value ($) Market Share 2015-2020
Table Alvizia Health Care Profile
Table Alvizia Health Care Product Introduction
Figure Alvizia Health Care Production and Growth Rate
Figure Alvizia Health Care Value ($) Market Share 2015-2020
Table Bayer AG Profile
Table Bayer AG Product Introduction
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Value ($) Market Share 2015-2020
Table Ranbaxy Laboratories Profile
Table Ranbaxy Laboratories Product Introduction
Figure Ranbaxy Laboratories Production and Growth Rate
Figure Ranbaxy Laboratories Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Product Introduction
Figure F. Hoffmann-La Roche AG Production and Growth Rate
Figure F. Hoffmann-La Roche AG Value ($) Market Share 2015-2020
Table Strides Pharma Science Profile
Table Strides Pharma Science Product Introduction
Figure Strides Pharma Science Production and Growth Rate
Figure Strides Pharma Science Value ($) Market Share 2015-2020
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Product Introduction
Figure Pfizer, Inc. Production and Growth Rate
Figure Pfizer, Inc. Value ($) Market Share 2015-2020
Table Ipca Laboratories Ltd Profile
Table Ipca Laboratories Ltd Product Introduction
Figure Ipca Laboratories Ltd Production and Growth Rate
Figure Ipca Laboratories Ltd Value ($) Market Share 2015-2020
Table GlaxoSmithKline Plc Profile
Table GlaxoSmithKline Plc Product Introduction
Figure GlaxoSmithKline Plc Production and Growth Rate
Figure GlaxoSmithKline Plc Value ($) Market Share 2015-2020
Table Market Driving Factors of Anti-malarial Drugs
Table Merger, Acquisition and New Investment
Table Global Anti-malarial Drugs Market Value ($) Forecast, by Type
Table Global Anti-malarial Drugs Market Volume Forecast, by Type
Figure Global Anti-malarial Drugs Market Value ($) and Growth Rate Forecast of Blood Schizonticides (2020-2025)
Figure Global Anti-malarial Drugs Market Volume ($) and Growth Rate Forecast of Blood Schizonticides (2020-2025)
Figure Global Anti-malarial Drugs Market Value ($) and Growth Rate Forecast of Gametocytocides (2020-2025)
Figure Global Anti-malarial Drugs Market Volume ($) and Growth Rate Forecast of Gametocytocides (2020-2025)
Figure Global Anti-malarial Drugs Market Value ($) and Growth Rate Forecast of Sporontocides (2020-2025)
Figure Global Anti-malarial Drugs Market Volume ($) and Growth Rate Forecast of Sporontocides (2020-2025)
Figure Global Anti-malarial Drugs Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Anti-malarial Drugs Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Falciparum Malaria (2020-2025)
Figure Market Volume and Growth Rate Forecast of Falciparum Malaria (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Vivax Malaria (2020-2025)
Figure Market Volume and Growth Rate Forecast of Vivax Malaria (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets